Tamoxifen in the management of pseudoangiomatous stromal Hyperplasia

Breast Journal

Volumn 7, Issue 6, 2001, Pages 434-439

  Pruthi, Sandhya ^a   Reynolds, Carol ^a   Johnson, Ruth E ^a   Gisvold, John J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Benign breast diseases; Low grade angiosarcoma; Stromal hyperplasia; Tamoxifen

Indexed keywords

TAMOXIFEN;

ADULT; ANGIOSARCOMA; ARTICLE; BREAST BIOPSY; BREAST FIBROADENOMA; BREAST HYPERPLASIA; BREAST SURGERY; BREAST TUMOR; CASE REPORT; CELL HYPERPLASIA; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAMMOGRAPHY; MASTALGIA; MASTECTOMY; MICROSCOPIC ANATOMY; PSEUDOANGIOMATOUS STROMAL HYPERPLASIA; STROMA CELL;

ADULT; ANGIOMATOSIS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST DISEASES; FEMALE; HUMANS; HYPERPLASIA; TAMOXIFEN;

EID: 0035660854     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4741.2001.07611.x     Document Type: Article

References (8)

1. Pseudoangiomatous hyperplasia of mammary stroma
2. Pseudoangiomatous stromal hyperplasia (PASH): A mammary stromal tumor with myofibroblastic differentiation
3. Pseudoangiomatous stromal hyperplasia: Mammographic and sonographic appearances
4. Pseudoangiomatous hyperplasia of mammary stroma: Some observations regarding its clinicopathologic spectrum
5. Immunocytochemical analysis of estrogen and progesterone receptors in benign stromal lesions of the breast: Evidence for hormonal etiology in pseudoangiomatous hyperplasia of mammary stroma
6. Pseudoangiomatous hyperplasia of male breast
7. Double-blind controlled trial of tamoxifen therapy for mastalgia
8. Tamoxifen for early breast cancer: An overview of the randomised trials